Document is current
Any future updates will be listed below
-
Authors
Huang, Jianguo
Chen, Mark https://orcid.org/0000-0001-5616-9321
Xu, Eric S. https://orcid.org/0000-0001-9933-9386
Luo, Lixia
Ma, Yan
Huang, Wesley
Floyd, Warren
Klann, Tyler S.
Kim, So Young
Gersbach, Charles A. https://orcid.org/0000-0003-1478-4013
Cardona, Diana M.
Kirsch, David G. https://orcid.org/0000-0002-2086-205X
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (T32GM007171, F30CA206424, R35CA197616)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
- License Information
-
More Information
Article History
Received: 7 July 2019
Accepted: 28 October 2019
First Online: 20 November 2019
Competing interests
: D.G.K. is a co-founder of XRAD Therapeutics, which is developing radiosensitizers, and D.G.K. is on the scientific advisory board and owns stock in Lumicell Inc, which is developing intraoperative imaging, but these interests do not overlap with the work in this manuscript.
